Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China flag China · Delayed Price · Currency is CNY
42.10
+0.22 (0.53%)
Nov 17, 2026, 3:00 PM CST

SHA:688050 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,14411,73217,25418,10724,26422,103
Market Cap Growth
-35.05%-32.01%-4.71%-25.37%9.78%21.53%
Enterprise Value
8,95911,88217,62517,74724,23221,769
Last Close Price
42.1060.1789.8394.00125.77114.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
33.3243.7544.4259.57104.27129.00
Forward PE
23.0026.5629.8546.1681.03105.28
PS Ratio
4.557.9112.2419.0441.8751.04
PB Ratio
2.743.956.557.6912.6412.70
P/TBV Ratio
3.994.888.309.9314.0114.16
P/FCF Ratio
56.2547.69944.35---
P/OCF Ratio
26.1431.7849.6285.1697.01100.79
PEG Ratio
-1.311.311.311.942.52

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.008.0112.5018.6641.8250.27
EV/EBITDA Ratio
16.1922.6631.1446.6489.28115.75
EV/EBIT Ratio
24.6932.5640.2957.59104.62137.88
EV/FCF Ratio
61.8848.30964.66---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.360.200.230.180.090.09
Debt / EBITDA Ratio
2.111.131.071.090.590.82
Debt / FCF Ratio
8.082.4433.33---
Net Debt / Equity Ratio
0.17-0.070.04-0.06-0.35-0.46
Net Debt / EBITDA Ratio
1.01-0.370.20-0.36-2.48-4.25
Net Debt / FCF Ratio
3.81-0.796.170.8732.258.69
Asset Turnover
0.410.400.430.360.270.24
Inventory Turnover
1.701.902.111.771.311.18
Quick Ratio
2.213.012.862.056.397.37
Current Ratio
3.243.943.952.717.198.02
Return on Equity (ROE)
7.36%8.59%15.51%13.38%12.42%10.21%
Return on Assets (ROA)
5.22%6.18%8.34%7.26%6.75%5.35%
Return on Invested Capital (ROIC)
8.12%10.99%15.82%15.53%18.22%18.78%
Return on Capital Employed (ROCE)
8.60%10.50%13.70%11.50%11.00%8.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
3.00%2.29%2.25%1.68%0.96%0.78%
FCF Yield
1.78%2.10%0.11%-0.87%-0.09%-0.42%
Dividend Yield
0.76%0.53%0.38%0.29%0.22%0.18%
Payout Ratio
37.14%33.36%18.17%20.19%19.10%17.81%
Buyback Yield / Dilution
-0.55%-1.10%0.27%-0.25%-0.17%-17.57%
Total Shareholder Return
0.21%-0.57%0.66%0.04%0.05%-17.39%